Transcript: Former CDC chief medical officer Dr. Debra Houry on “Face the Nation with Margaret Brennan,” July 5, 2026

Transcript: Dr. Debra Houry on "Face the Nation with Margaret Brennan," July 5, 2026

Former CDC Chief Medical Officer Reflects on Leadership and Challenges

Transcript - The interview featured Dr. Debra Houry, who served as the chief medical officer at the Centers for Disease Control and Prevention (CDC) for a decade before leaving in August 2025. The discussion took place during a taped episode of "Face the Nation with Margaret Brennan" on July 1, 2026, and a portion of it aired on July 5, 2026. Brennan opened the conversation by thanking Houry for her time, setting the stage for an in-depth exploration of her experiences during the Trump administration.

Houry expressed cautious optimism about the Trump administration's early days, noting that initial efforts in public health, such as suicide prevention programs, had shown promise. However, she acknowledged underlying concerns about potential shifts in the agency's focus. As the transition lead, she played a key role in preparing the CDC for collaboration with the new leadership, aiming to maintain scientific integrity while aligning with the administration's goals. Yet, her apprehensions grew as the political landscape evolved.

Preserving Evidence: The Role of Emails

Brennan inquired about Houry’s decision to save emails during her tenure. Houry explained that her approach was rooted in clinical practices, where thorough documentation is standard. She emphasized that as an official overseeing critical decisions, she believed it was essential to track how policies were shaped, particularly when conflicts of interest or political influence began to affect scientific processes.

Houry’s decision to retain and share emails was strategic. She highlighted that her role as a capstone official ensured her communications would be accessible under the Freedom of Information Act, but she felt an added responsibility to preserve a record of the agency’s operations. This became even more significant as the CDC’s work came under scrutiny, with political appointees influencing scientific priorities. Her collection of documents was intended to create a transparent account of the decisions made during this period.

Acting Director and Political Dynamics

Brennan noted that Houry had served as acting CDC director for a brief time. Houry clarified that while she was never officially named by the Trump administration, she took on the role through an internal memo and the agency’s operating plan. This transition period was marked by both collaboration and tension, as she navigated the complexities of aligning with new leadership while safeguarding the CDC’s mission.

Houry described the acting director position as a temporary but pivotal role. She explained that the memo from the Trump administration provided a framework for her leadership, though the formal appointment process was delayed. This period allowed her to observe the administration’s approach to the CDC’s operations, which she found both challenging and historic.

Historic Shifts at the CDC

When asked about the significance of the 250 emails and documents released by the Senate committee, Houry underscored the changes she witnessed at the CDC. She noted that the agency’s transformation began almost immediately under the new administration, with executive orders targeting key aspects of its work. These actions, she argued, represented a departure from the CDC’s core mission of public health science.

Houry pointed to the removal of gender-related content as a central issue. She explained that the CDC’s websites were revised to eliminate references to gender ideology, including terms like “gender” in data sets and guidance for treating sexually transmitted diseases. These changes, she argued, were not just symbolic but had real implications for public health communication and the credibility of scientific research.

Legacy and Reflection

Reflecting on the broader impact of the administration’s policies, Houry stressed the importance of preserving the historical record. She believed that the CDC’s transformation during this time would be studied in the future, and she wanted to ensure that the evidence of these changes was available for scrutiny. Her actions, she said, were driven by a commitment to transparency and the protection of scientific integrity.

Houry’s emphasis on the importance of these documents highlights the urgency of maintaining scientific accuracy in public health messaging. The removal of information about transgender health and gender-related research, she argued, was a deliberate effort to reshape the narrative around medical practices. Despite these challenges, she remained dedicated to her role, ensuring that the CDC’s work was documented for future reference.

The interview concluded with Houry reaffirming her belief in the CDC’s mission and the necessity of preserving its history. Her insights provide a critical perspective on the intersection of politics and public health, underscoring the need for accountability in scientific governance. As the agency continues to evolve, the records she saved serve as a testament to the challenges faced during this transformative period.